A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...

Quest will offer the first FDA-approved blood test to help detect Alzheimer’s-related amyloid pathology in patients with ...

Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly tripling in price.

Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...

A major drug bust in St. Johns County leaves two people arrested and a neighborhood rattled.

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

When I visited a nursing home for several years, I met two men who were there after suffering major injuries taking care of their wives. One broke a hip, another shattered a knee. Both times, they ...

Cognitive decline can range from mild forgetfulness to serious memory problems like dementia, which can affect a person’s ...

A new Medicare program called GUIDE is offering 72 hours of annual respite care to dementia caregivers in Southwest Florida, providing much-needed relief to families like Patrick Oliva's.

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the ...

A new dosing regimen for Kisunla, to help lower the risk of certain side effects, has been approved by the U.S. Food and Drug ...